(Q72938743)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285702%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Effect of acyclovir treatment on acute and chronic murine cytomegalovirus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285702%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

cytomegaloviral disease

1 reference

L. A. Glasgow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285702

16 September 2023

J. T. Richards

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285702

16 September 2023

E. R. Kern

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6285702

16 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6285702

16 September 2023

publication date

1 July 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285702%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

20 July 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6285702

full work available at URL

16 September 2023

https://api.elsevier.com/content/article/PII:000293438290078X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

https://api.elsevier.com/content/article/PII:000293438290078X?httpAccept=text/plain

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

American Journal of Medicine

16 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285702%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285702%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

1A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285702%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

132-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285702%20AND%20SRC:MED&resulttype=core&format=json

Treatment of congenital cytomegalic inclusion disease with antiviral agents

30 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease

16 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Effect of adenine arabinoside on cytomegalovirus infections

16 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Clinical Efficacy of Adenine Arabinoside in Therapy of Cytomegalovirus Infections in Renal Allograft Recipients

16 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Effect of Human Exogenous Leukocyte Interferon in Cytomegalovirus Infections

16 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Effect of Leukocyte Interferon on Urinary Excretion of Cytomegalovirus by Infants

16 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections

16 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Prevention and Treatment of Cytomegalovirus Infection

16 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Production and therapy of Proteus mirabilis pyelonephritis in mice undergoing chronic diuresis

16 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Effective Antiviral Chemotherapy in Cytomegalovirus Infection of Mice

16 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Treatment of a Murine Cytomegalovirus Infection with Exogenous Interferon, Polyinosinic-Polycytidylic Acid, and Polyinosinic-Polycytidylic Acid–Poly- l -Lysine Complex

16 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

16 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group

16 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent

16 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

16 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in Mice

16 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate

16 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

The in vitro activity of Acyclovir and related compounds against cytomegalovirus infections

16 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]

16 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Thymidine kinase activity in mouse 3T3 cells infected by murine cytomegalovirus (MCV)

16 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Thymidine-kinase in cytomegalovirus infected cells

16 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Efficacy of acyclovir against mouse cytomegalovirus in vivo

16 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

Thymidine kinase activity in mouse embryo fibroblast cells infected with murine cytomegalovirus

16 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90078-X

16 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6285702%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference